CSIMC Approves Listing of 12 APIs, Parjeta Gets 5% Premium for Usefulness

August 23, 2013
CSIMC general assembly held on August 21 The Central Social Insurance Medical Council (CSIMC), an advisory body to the health minister, approved on August 21 the listing of 12 active pharmaceutical ingredients (APIs)/25 products including Chugai Pharmaceutical’s breast cancer drug...read more